Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Pointe A Pitre

2 clinical trials in Pointe A Pitre, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Pointe A Pitre at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Pointe A Pitre

Open in trial search

HIV infection

Recruiting

Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir
  • Sponsor:ANRS Maladies Infectieuses Emergentes

Asthma

Not recruiting

Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Mepolizumab
  • Sponsor:Cliniques Universitaires Saint-Luc

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Pointe A Pitre

What the registry says about research in the country

01 Virus Diseases

Clinical research in virus diseases in Pointe-à-Pitre Cedex is centered on HIV management, with studies looking at whether simplified treatment approaches can maintain strong virological control in people whose infection is already well suppressed.

  • Comparing two-drug maintenance strategies for ongoing HIV care
  • Assessing sustained virological success in people living with HIV
  • Exploring treatment options that preserve control while reducing treatment burden

This research aims to support effective long-term care by testing whether new maintenance regimens can keep the virus under control without loss of effectiveness.

02 Neoplasms

Work in neoplasms focuses on prostatic adenocarcinoma with a high risk of recurrence, examining whether adjuvant hormonal treatment can improve long-term outcomes after surgery.

  • Studying hormone-based treatment after radical prostatectomy
  • Evaluating survival without metastases over the long term
  • Targeting patients at high risk of cancer recurrence

The goal is to better define how additional post-surgical therapy may help prevent relapse and improve disease control in prostate cancer.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.